Molecular Basis of G6PD Deficiency In principle, genetically determined deficiency of G6PD, like that of any other protein, might be attributed either to quantitative changes, such as mutations that affect the amount of the enzyme but not its structure, or to qualitative changes, such as mutations that affect the structure of the enzyme and hence its stability or catalytic efficiency
The idea is to avoid the common problem seen with GLP 1 weight loss drugs like Wegovy and Mounjaro, where many pic.twitter.com/0ICUH8FdLX Gandalv (@Microinteracti1) January 26, 2026 Biotech company Fractyl Health is preparing clinical trials of a gene therapy called Rejuva, which delivers genetic instructions directly to the pancreas
Dig Dis Sci 1992
Anaesth Crit Care Pain
Mounjaro (Tirzepatide) is an injectable medication that was initially approved for managing type 2 diabetes , but it has shown significant positive results for weight loss as well
Promotes Gut Health: Potential benefits for the healing of intestinal tissue